Good Morning Meeting | Promise and Perils of Subgroup Analysis in Early Drug Development
June 21, 2023
Copenhagen, Denmark
Subgroup Analysis in Early Drug Development
Homepage Featured Webinar
Homepage Featured Webinar
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras vel sagittis libero, a lacinia nisi. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec nec nisl turpis. Pellentesque pretium pellentesque maximus. Nam efficitur massa justo, eget laoreet odio congue convallis. Proin sagittis mauris sit amet justo cursus, sit amet porta eros eleifend. Nullam felis tortor, pharetra a consequat eget, luctus non massa. Cras sed efficitur felis, sollicitudin gravida eros. Mauris congue efficitur tempor.
Renseigner une description via Articles > Categories > Homepage Featured Webinar > Champ 'Description' pour remplacer ce Lorem ipsum.
GPC – A novel statistical method for outcome analysis and reporting of prioritized composite endpoints
May 16, 2023
Join IDDI webinar to learn how the GPC method can be used to design clinical trials with multiple endpoints. You…
Supporting Shared Decision-making and Communication in Breast Cancer: The ShareView Project
March 30, 2023
Join IDDI webinar to learn more about the ShareView Project which investigated communication approaches and shared decision-making practices across Europe…
The Added Value of Biostatistics-Driven Randomization and Trial Supply Management System (RTSM)
January 25, 2023
Join IDDI and Clario’s experts to learn how combined advanced biostatistics and innovative integrated randomization and trial supply management system…
Why Do So Many Phase III Clinical Trials Fail?
December 6, 2022
Learn on statistical explanations for a large proportion of Phase III clinical trials failures, and how to address both the…
Optimizing Rare Disease Trials: Trial Design & Execution
October 27, 2022
Join August Research and IDDI’s experts in the 60-minute complimentary webinar to gain insights into trial design and execution strategies…
The Benefit-Risk Assessment of New Treatments: The Health Technology Assessment (HTA) Process
September 22, 2022
September 22, 2022 | 5:00-6:00 PM CEST | 11:00 AM – 12:00 PM EDT ABSTRACT The increasing cost of new…
Conversation between a Sponsor and a Statistician about Phase II/III trials in oncology
June 23, 2022
Learn on the features, advantages and disadvantages of adaptive designs and group-sequential designs and their regulatory aspects of Phase II/III trials…
Risk-Based Fraud Detection: How Centralized Monitoring Can Boost Data Quality
March 24, 2022 — March 24, 2022
This webinar presented the results of a new study that further demonstrated that risk-based monitoring is an efficient tool to…
Assessing activity in early-phase trials in oncology: current designs for expansion cohorts and phase 2
December 2, 2021
Be updated on different types of Bayesian and frequentist designs that may be used for expansion cohorts in phase 1…